Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial
Titel:
Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial
Auteur:
Tan, Winston W. Allred, Jacob B. Salim, Muhammad Flynn, Patrick Fishkin, Paul A.S. Stella, Philip J. Wiesenfeld, Martin Bernath, Albert M. Fitch, Tom R. Perez, Edith A.